Skip to main content

Closed

QTTB: Q32 Bio Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+0.0% / yr

Operating margin39.8%

ROIC35.7%

Financially safe

Strong

Debt / equity0.29×

Interest coverage21.4×

Current ratio5.36×

Valuation

Unrated

P/E ratio5.9×

Q32 Bio Inc.

QTTBNASDAQ Global Market·USD·Closed

Q32 Bio Inc.

QTTBNASDAQ·USD·Closed

$15.68

+0.77%

$15.68

+$0.12 (0.77%)

52W Range

64thpctl

Volume

0.26×avg

Mkt Cap

200.33MUSD

P/E

5.9TTM

Div Yield

–ann

52W Range

64thpctl

Volume

0.26×avg

Market Cap

200.33MUSD

P/E Ratio

5.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings